СПИСОК ЛИТЕРАТУРЫ

1. Вакуловская, Е. Первый опыт применения флуоресцентной лапароскопии у больных с раком яичника / Е. Вакуловская, А.Рубин, Б. Поддубный и др. // Рос. биотерапевт. журн. – 2005. – Т.1, № 4.

2. Гайдар, Б.В. Очерк развития кафедры и клиники нейрохирургии Российской военно-медицинской академии / Б.В. Гайдар // Нейрохирургия. – 2000. – № 1/2. – С. 52–58.

3. Гладков, А.А. Люминисцентный анализ в медицине / А.А. Гладков.– Кишенев, 1958. – С. 3–115.

4. Гублер, Е.В. Вычислительные методы анализа и распознавания патологических процессов / Е.В.Гублер. – М.: Медицина, 1978. – С. 296–300.

5. Диаконис, П. Статистические методы с интенсивным использованием ЭВМ

/ П.Диаконис, Б. Эфрон // В мире науки. –1993. – № 3. – С. 60 –72.

6. Ластед, Л. Введение в проблему принятия решений в медицине / Л. Ластед.

– Медицина, 1971. – С.125–130.

7. Кобяков, Г.Л. Химиотерапия в комплексном лечении больных с первичными злокачественными опухолями головного мозга : автореф. дис. … д-ра. мед. наук. : 14.01.18 : 14.01.12 / Кобяков Григорий Львович – М., 2011. – 48 с.

8. Коновалов, А.Н. Использование навигационной системы Stealth Station для удаления опухолей головного мозга / А.Н. Коновалов, А.Г. Меликян, Ю.В. Кушель и др. // Вопр. нейрохирургии. – 2000. – № 2. – С. 2–5.

9. Коновалов, А.Н. Стандарты, рекомендации и опции в лечении глиальных опухолей головного мозга у взрослых / А.Н.Коновалов, А.А. Потапов, В.А.Лошаков и др. // Вопр. нейрохирургии. – 2006. – № 2. – С. 3–11.

10. Кривошапкин, А.Л. Нейронавигация в малоинвазивной хирургии опухолей головного мозга / Кривошапкин А.Л., Сёмин П.А., Мелиди Е.Г. и др. // Материалы III съезда нейрохирургов России – СПб., 2002. – С. 119.

11. Кудинова, Н.В. Фотодинамическая терапия рака. Поиск идеального фотосенсибилизатора / Кудинова Н.В., Березов Т.Т. // Биомед. химия. – 2009. – Т. 55, № 5.

12. Лапшин Р.А. Интраоперационная навигация в хирургическом лечении опухолей головного мозга : дис. … канд. мед. наук.: 14.00.28 / Лапшин Радион Анатольевич. – СПб., 2006. – 170 с.

13. Лосев Ю.А. Эпидемиология первичных опухолей головного мозга в сельской местности (на модели Ленинградской области) : автореф. дис. … канд. мед. наук.: 14.00.33 / Лосев Юрий Алексеевич. – СПб., 2003. – 23 с.

14. Лошаков, В.А. Планирование хирургического доступа при удалении внутримозговых опухолей больших полушарий с использованием функциональной МРТ, навигационных систем и электрофизиологического мониторинга / В.А. Лошаков В.А., В.Ю. Жуков, И.Н.Пронин и др. // Вопр. нейрохирургии. – 2010. – № 2. – С. 9–14.

15. Лошаков, В.А. Использование функциональной МРТ, навигационной МРТ, навигционных систем и электрофизиологического мониторинга в планировании хирургического доступа при удалении внутримозговых опухолей, расположенных вблизи функционально значимых зон головного мозга / В.А. Лошаков, В.Ю. Жуков, И.Н. Пронин и др. // Нейрохирургия. – 2011. – Т.2, № 24. – С. 18 –23.

16. Мартынов, Б.В. Прогностические факторы у больных с глиомами: симптомно-синдромальный анализ / Б.В. Мартынов, В.Е. Парфенов, Г.Е. Труфанов и др. // Вестн. Рос. Воен.-мед. акад. – 2010. – №1(29). – С. 7–14.

17. Мацко Д.Е. Патологическая анатомия важнейших хирургических заболеваний нервной системы / Д.Е. Мацко // Практическая нейрохирургия : рук. для врачей / под ред. Б.В. Гайдара. – СПб., 2002. – Гл.26. – С. 605–643.

18. Миронов А.Ф. Фотодинамическая терапия рака – новый эффективный метод диагностики и лечения злокачественных опухолей / А.Ф. Миронов // Соросов. образоват. жур. –1996. –№8. – С. 32–40.

19. Мостеллер, Ф. Анализ данных и регрессия / Ф. Мостеллер, Дж. Тьюки. – М.

: Финансы и статистика, 1982. – 497 с.

20. Никифоров, Б.М. Опухоли головного мозга / Б.М. Никифоров, Д.Е. Мацко.

– СПб.: Питер, 2003. – 320 с .

21. Олюшин, В.Е. Комбинированная специфическая противоопухолевая иммунотерапия в лечении больных с продолженным ростом глиобластом: результаты пилотного исследования / В.Е.

22. Олюшин, В.Е. Глиальные опухоли головного мозга: краткий обзор литературы и протокол лечения больных / В.Е. Олюшин // Нейрохирургия. – 2005. –

№ 4. – С. 41–47.

23. Олюшин, В.Е. Современный классификационный подход к опухолям центральной нервной системы / В.Е. Олюшин, А.Ю. Улитин, Д.Е. Мацко // Вопр. нейрохирургии. – 2008. – №4. – С. 45–47.

24. Олюшин, В.Е. Новые технологии в терапии больных здокачественными глиомами полушарий большого мозга / В.Е. Олюшин, М.В. Филатов, А.Ю. Улитин и др. // Практ. онкология. – 2013. – Т.14, № 3. –С. 175–179.

25. Патока, Е. Флюоресцентная диагностики рака легкого при пероральном пути введения препарата «Аласенс» / Е. Патока, С. Харнас, В. Рыбин и др. // Тез. науч. – практ. конф. "Отечественные противоопухолевые препараты". – М., 2002. – С. 136–137.

26. Потапов, А.А Интраоперационная флуоресцентная диагностика и лазерная спектроскопия в хирургии глиальных опухолей головного мозга / А.А. Потапов, А.Г. Гаврилов, С.А. Горяйнов // Вопр. нейрохирургии. – 2012. – Т. 76, № 5. – С. 3– 12.

27. Парфенов, В.Е. Опухоли головного мозга / Парфенов В.Е., Свистов Д.В., Мартынов Б.В. // Сборник лекций по актуальным вопросам нейрохирургии. – СПб., 2008. – С. 3–28.

28. Савелло, А.В. Комплексное дифференцированное применение методов пред- и интраоперационной визуализации, нейронавигации и рентгенохирургии на этапе хирургического лечения пациентов с внутричерепными опухолями : автореф.

дис.

29. Свистов, Д.В. Течение послеоперационного периода у больных с глиомами головного мозга при различных объемах и видах хирургического вмешательства / Свистов Д.В., Парфенов В.Е., Мартынов Б.В. и др. // Вестн. хирургии им. И.И. Грекова. – 2011. – Т. 170, № 6. – С. 15–18.

30. Славин, М.Б. Методы системного анализа в медицинских исследованиях / М.Б. Славин. – М.: Медицина, 1989. – 304 с.

31. Ступак, В.В. Отдаленные результаты комплексного лечения злокачественных глиом головного мозга с использованием комбинированной иммунотерапии / В.В. Ступак, М.И. Центнер, Ю.П. Козлов и др. // Всерос. конф.

«Комбинированное лечение опухолей головного мозга» : материалы. – Екатеринбург, 2004. – C.107–109.

32. Терновой, С.К. Компьютерная и магнитно-резонансная томография в оценке радикальности хирургического лечения опухолей головного мозга / С.К. Терновой, А.В. Араблинский, Г.Ю. Евзиков и др. // Мед. визуализация. – 2006. – № 6. – С.84.

33. Улитин, А.Ю. Эпидемиология первичных опухолей головного мозга среди населения крупного города и пути совершенствования организации медицинской помощи больным с данной патологией (на модели Санкт-Петербурга) : дис. … канд. мед. наук. : 14.00.28 / Улитин Алексей Юрьевич. – СПб., 1997. – 41 с.

34. Эфрон, Б. Нетрадиционные методы многомерного статистического анализа / Б. Эфрон. – М.: Финансы и статистика,1988. – 348 с.

35. Ahmadloo, N. Treatment outcome and prognostic factors of adult glioblastoma multiforme / N. Ahmadloo, A. Kani, M. Mohammadianpanah et al. // J. Egypt. Natl. Canc. Inst. – 2013. – Vol. 25, N 1. – P. 21–30.

36. Aguilera, D.G. Glioblastoma multiforme in a patient with chronic granulomatous disease treated with subtotal resection, radiation, and thalidomide: case report of a long- term survivor / D.G. Aguilera, T. Tomita, V. Rajaram et al. // J. Pediatr. Hematol. Oncol. – 2009. – Vol. 31, N 12. – P. 965–969.

37.

38. Ando, T. Precise comparison of protoporphyrin IX fluorescence spectra with pathological results for brain tumor tissue identification / T. Ando, E. Kobayashi, H. Liao et al. // Brain tumor pathol. – 2011. – Vol. 28, N 1. – P. 43–51.

39. Armstrong, C.L. Late cognitive and radiographic changes related to radiotherapy

/ C.L. Armstrong, J.V. Hunter, G.E. Ledakis et al. // Neurology. – 2002. – Vol. 59, N 1. – P. 40–48.

40. Armstrong, T.S. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) / T.S. Armstrong, T. Mendoza, I. Gring et al. // J. Neurooncol. – 2006. – Vol. 80, N1. – P. 27–35.

41. Brandes, A.A. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients / A.A. Brandes, E. Franceschi, A. Tosoni et al. // Clin Oncol. – 2008. – Vol. 26, N 13. – P. 2192–2197.

42. Enam, S.A. Malignant glioma / S.A. Enam, J.P. Rock, М.L. Rosenblum // Neurooncology. The Essentials. – New York, 2000. – Ch. 31. – P. 309.

43. Behin, A. Primary brain tumours in adults / A. Behin – Lancet Seminar, 2003. — P. 323–325.

44. Bernstein, M., Berger, M.S. // Neurooncology. The Essentials. – New York, 2000. – P. 495.

45. Black, P. Management of malignant glioma: role of surgery in relation to multimodality therapy / P. Black // J. Neurovirol. – 1998. – Vol. 4, N 2. – P. 227–236.

46. Bloch, O. Impact of extent of resection for recurrent glioblastoma on overall survival / O. Bloch, S.J. Han, S. Cha et al. // J.Neurosurg. – 2012. – Vol. 117, N 6. – P. 1032-1038.

47. Bogaards, A. Increased brain tumor resection using fluorescence image guidance in a preclinical model / A. Bogaards, A.Varma, S.P.Collens et al.

48. Bondy, M.L. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium / M.L. Bondy, M.E. Scheurer , B. Malmer et al. // Cancer. – 2008. – Vol. 113, N 7. – P. 1953–1968.

49. Bottomley, A. Health related quality of lifeoutcomes in cancer clinical trials / A. Bottomley, H. Flechtner, F. Efficace et al. // Eur. J. Cancer. – 2005. – Vol. 41, N 3. – P. 1697–1709.

50. Brannen, J.H. Reliability of functional MR imaging with word-generation tasks for mapping Broca’s area / J.H.Brannen, B. Badie, C.H. Moritz et al. // AJNR. Am. J. Neuroradiol. – 2001. – Vol. 22, N 9. – P. 1711–8.

51. Britz, G.W. Intracarotid RMP-7 enhanced indocyanine green staining of tumors in a rat glioma model / G.W. Britz, S. Ghatan, A.M. Spence et al. // J. Neurooncol. – 2002. – Vol. 56, N 3. – P. 227–232.

52. Brown, P.D. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival / P.D. Brown, M.J. Maurer, T.A. Rummans et al. // Neurosurg. – 2005. – Vol. 57, N 3. – P. 495–504.

53. Brower V. Early-stage progress on glioma vaccines / V. Brower // J. Natl. Cancer Inst. – 2011. – Vol. 103, N 18. – Р.1361–1362.

54. Buckner, J.C. Factors influencing survival in high-grade gliomas / J.C. Buckner // Semin. Oncol. – 2003. – Vol. 30, N 6. – P.10–14.

55. Buckner, J.C. A phase III study of radiation therapy plus carmustine with or with- out recombinant interferon-alpha in the treatment of patients with newly diagnosed high- grade glioma / J.C. Buckner, P.J. Schomberg, W.L. McGinnis et al. // Cancer. – 2001. – Vol. 92, N 2. – P.420–433.

56. Burger P.C., Scheithauer B.W. Tumors of the Central Nervous System. – Washington, DC: Armed Forces Institute of Pathology, 1994. – P. 452.

57. Butowski, N. Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme / N. Butowski, K.R. Lamborn, M.S. Berger et al. // J. Neurooncol. – 2007. – Vol. 85, N 1. – P. 87–94.

58. Calzavara-Pinton, P.G. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma / P.G. Calzavara-Pinton , M. Venturini, R. Sala et al. // Br. J. Dermatol. – 2008. – Vol. 159, N 1. – P. 137–44.

59. Campos, B. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas / B.Campos, J.L. Bermejo, L. Han. et al. // Cancer Sci. - 2011. – Vol. 102, N 2. – Р. 387–392.

60. Carapella, C.M. Surgery of malignant gliomas: advances and perspectives / C.M. Carapella, S. Telera, P.A. Oppido // Curr Opin Oncol. – 2011. – Vol. 23, N 6. – P. 624 – 629.

61. Clarke J.L. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma / J.L. Clarke,

F.M. Iwamoto, J. Sul et al. // J. Clin. Oncol. – 2009. – Vol. 27, N 2. – P. 3861–3867.

62. Chaichana, K.L. Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection / K.L. Chaichana, M.J. McGirt, J. Frazier et al.

// J. Neurooncol. – 2008. – Vol. 89, N 2. – P. 219–224.

63. Chaichana, K.L. A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme / K.L. Chaichana, S.Parker, A.Olivi et al. // J. Neurosurg. – 2010. – Vol. 112 – P. 997–1004.

64. Chaichana, K.L. Factors associated with survival for patients with glioblastoma with poor pre-operative functional status / K.L. Chaichana, J.C. Martinez-Gutierrez, R.D. Garza-Ramos et al. // J. Clin. Neurosci. – 2013. – Vol. 20, N 6. – P. 818–823.

65. Chaichana, K.L. Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma / K.L. Chaichana, C. Pendleton, L. Chambless et al. // J. Clin.Neurosci. – 2013. – Vol. 20, N 10. – P. 1422–1426.

66. Chan, W.C.W. Luminescent quantum dots for multiplexed biological detection and imaging / W.C.W. Chan, D.J. Maxwell, X. Gao et al. // Curr. Opin. Biotechnol. – 2002. – Vol. 13, N 1. – P. 40–46.

67. Chang, S.M. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project / S.M.

Chang, I.F. Parney, M. McDermott et al. // J. Neurosurg. – 2003. – Vol. 98, N 6. – P. 1175–1181.

68. Chang, S.M. Patterns of care for adults with newly diagnosed malignant glioma /

S.M. Chang, I.F. Parney, W. Huang et al. // JAMA – 2005. – Vol. 293, N 5. – P.557–564.

69. Cheng, JX Health-related quality of life in patients with high-grade glioma / J.X. Cheng, X. Zhang, B.L. Liu // Neurooncol. – 2009. – Vol. 11, N 1. – P. 41–50.

70. Collaud, S. On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. S. Collaud, A Juzeniene, J. Moan et al. // Curr. Med. Chem. Antiсancer. Agents. – 2004. – Vol. 4, N 3. – P. 301–316.

71. Coston, H. Сombination of «Foscan» mediated fluorescence guided resection and fotodinamic treatment as new therapeutic concept for malignant brain tumors / H. Coston

// Med. Laser. Applicat. – 2006. – Vol. 21. – P. 285–290.

72. Croce, A.C. Diagnostic potential of autofluorescence for an assisted intraoperative delineation of glioblastoma resection margins / A.C. Croce, S. Fiorani,

D. Locatelli et al. // Photochem. Photobiol. – 2003. – Vol. 77, N 3. – P. 309–318.

73. Curran, W.J. Does extent of surgery influence outcome for astro- cytoma with atypical or anaplastic foci(AAF)?A report from three Radiation Therapy Oncology Group (RTOG)trials / W.J. Curran, C.B. Scott, J. Horton et al. // J. Neurooncol. – 1992. – Vol. 12, N 3. – P. 219–227.

74. DaCosta, R.S. Molecular fluorescence excitationemission matrices relevant to tissue spectroscopy / R.S. DaCosta, H. Andersson, B.C. Wilson // Photochem. Photobiol.

– 2003. – Vol.78, N 4. – P. 384–392.

75. Daigle, K. Effects of surgical resection on the evolution of quality of life in newly diagnosed patients with glioblastoma: a report on 19 patients surviving to follow-up / K. Daigle, D. Fortin, D. Mathieu et al. // Curr. Med. Res. Opin. – 2013. – Vol. 29, N 10. – P. 1307–1313.

76. Daneyemez, M. Radical surgery and reoperation in supratentorial malignant glial tumors / M. Daneyemez, F.Gezen, Z. Canakci et al. // Minim. Invasive Neurosurg. – 1998.

– Vol. 41, N 4. – P. 209–213.

77. Das, K.K. Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome / K.K. Das, A. Mehrotra, A.P. Nair et al. // Child. Nerv. Syst. – 1998. – Vol. 28, N 12. – P. 2055–2062.

78. Dellaretti, M. Diffuse brainstem glioma: prognostic factors / M. Dellaretti, N. Reyns, G. Tauzet et al. // Journal of Neurosurgery November. – 2012. – Vol. 117, N 5. – P. 807-981.

79. Dubertret, B. In vivo imaging of quantum dots encapsulated in phospholipid micelles / B. Dubertret, P. Skourides, D.J. Norris et al. // Science. – 2002. – Vol. 298, N 5599. – P. 1759–1762.

80. Duffau, H. Intraoperative mapping of the cortical areas involved in multiplication and subtraction: an electrostimulation study in a patient with a left parietal glioma / H. Duffau, D. Denvil, M. Lopes et al. // J. Neurol. Neurosurg. Psychiatry. – 2002. – Vol. 73, N 6. – P. 733–738.

81. Duffau, H. Intraoperative subcortical stimulation mapping of language pathways in a consecutive series of 115 patients with Grade II glioma in the left dominant hemisphere / H. Duffau, S.T. Peggy Gatignol, E. Mandonnet et al. // J. Neurosurg. – 2008.

– Vol. 109, N 3. – P. 461–471.

82. Dunn, J. Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy / J. Dunn , A. Baborie , F. Alam et al. // J. Cancer. – 2009. – Vol. 101, N 1. – P. 124–131.

83. Duran, I. Low-grade gliomas: management issues / I. Duran, J. Raizer // Expert. Rev. Anticancer Ther. – 2007. – Vol. 7, N 12. – P. 115–121.

84. Eagan, R.T. Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma / R.T. Eagan, D.S. Childs, D.D. Layton et al. // JAMA. – 1979. – Vol. 241, N 19. – P. 2046–2050.

85. Efficace, F, Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients / F. Efficace, A. Bottomley // Eur. J. Cancer. – 2002. – Vol. 38, N 14. – P. 1824–1831.

86. Eisner, W. Use of neuronavigation and electrophysiology in surgery of subcortically located lesions in the sensorimotor strip/ J. Burtscher, R. Bale // J. Neurol. Neurosurg. Psychiatry. – 2002. – Vol. 72, N 3. – P. 378–381.

87. Enam, S.A. Malignant glioma / S.A. Enam, J.P. Rock, М.L. Rosenblum — Neurooncology. The Essentials – New York, 2000. – Ch. 31. – P. 309–318.

88. Ericson, M.B. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome / M.B. Ericson, C. Sandberg , B. Stenquist et al. // Brit. J. Dermatol.– 2004. – Vol. 151, N 6. – P. 1204–1212.

89. Eyüpoglu, I.Y. Surgical resection of malignant gliomas role in optimizing patient outcome / I.Y. Eyüpoglu, M. Buchfelder, N.E. Savaskan // Nat. Rev. Neurol. – 2013. – Vol. 9, N 3. – P. 141–151.

90. Ewelt, C. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence / C. Ewelt, F.W. Floeth, J. Felsberg et al. // Clin. Neurol. Neurosurg. – 2011. – Vol. 113, N 7. – P. 541–547.

91. Friesen, S.A. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review) / S.A. Friesen, G.O. Hjortland, S.J. Madsen et al. // Int. J. Oncol.

– 2002. – Vol. 21, N 3. – P. 577–582.

92. Folstein, M.F. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician / M.F. Folstein, S.E. Folstein, P.R. McHugh // J. Psychiatr. Res. – 1975. – Vol. 12, N 3. – P. 189–198.

93. Gaspar, L.E. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment / L.E. Gaspar, B.J. Fisher, D.R. Macdonald et al. // Int. J. Radiat. Oncol. Biol. Phys. – 1992. – Vol. 24, N 1. – P. 55–57.

94. Gao, H. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis: Laboratory investigation / H. Gao, B. Yu, Y.Yan et al. // J. Neurosurg. – 2013. – Vol. 118, N 4. – P. 846–853.

95. Georgakoudi, I. NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes / I. Georgakoudi, B.C. Jacobson, M.G. Müller et al. // Cancer Res. – 2002. – Vol. 62, N 3. – P. 682–687.

96. Gilbert M.R. The treatment of malignant gliomas / M.R. Gilbert, M. Loghin // Curr. Treat. Options Neurol. – 2005. – Vol. 7, N 4. – P. 293–303.

97. Giovagnoli, A.R. Facets and determinants of quality of life in patients with recurrent high grade glioma / A.R. Giovagnoli, A. Silvani, E. Colombo et al. // J. Neurol. Neurosurg. Psychiatry. – 2005. – Vol. 76, N 4. – P. 562–568.

98. Glantz, M.J. Concurrent chemotherapy and radiotherapy in patients with brain tumors / M.J. Glantz, L.Kim, H.Choy et al. // Oncology (Williston Park). – 1999. – Vol. 13, N 10. – P. 78–82.

99. Gomer, C.J. Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions / C.J. Gomer, N.J. Razum // Photochem. Photobiol. – 1984. – Vol. 40, N 4. – P. 435–439.

100. Gonzlez-Darder J.M. Multimodal navigation in the functional microsurgical resection of intrinsic brain tumors located in eloquent motor areas: role of tractography / J.M. Gonzlez-Darder, P. Gonzlez-lopez, F. Talamantes // Neurosurg. Focus. –2010. – Vol. 28, N 2. – P. 5–8.

101. Gorlia, T. New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials / T. Gorlia, R. Stupp, A.A. Brandes et al. // Eur. J. Cancer. – 2012. – Vol. 48, N 8. – P. 1176–1184.

102. Grant, R. Overview brain tumour diagnosis and management / R. Grant // J. Neurol. Neurosurg. Psychiatry. – 2004. – Vol. 75, N 2. – P. 18–23.

103. Greenberg, M.S. Greenberg // Handbook of neurosurgery – Thieme Medical Publishers. – New-York, 2001. – P. 431.

104. Gupta, A.K. Photodynamic Therapy and Topical Aminolevulinic Acid An Overview / A.K. Gupta, J.E. Ryder // Am. J. Clin. Dermatol. – 2003. – Vol. 4, N 4. – P. 699– 708.

105. Gulati, S. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma / S.Gulati,

A.S. Jakola, U.S. Nerland et al. // World Neurosurg. – 2011. – Vol. 76, N 6. – P. 572–579.

106. Haberland, N. Neuronavigation in surgery of intracranial and spinal tumors / N. Haberland, K. Ebmeier, R. Hliscs et al. // J. Cancer Res.Clin. Oncol. – 2000. – Vol. 126, N 9.

– P. 529–541.

107. Haglund, M.M. Enhanced optical imaging of human gliomas and tumor margins /

M.M. Haglund, M.S. Berger, D.W. Hochman // Neurosurg. – 1996. – Vol. 38 – P. 308– 317.

108. Hefti, M. 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high- grade glioma surgery: a one-year experience at a single institutuion / M. Hefti, M.G. von Campe , M. Moschopulos et al. // Swiss. Med. Wkly. – 2008. – Vol. 138, N 11. – P. 180– 185.

109. Hegi, M.E. MGMT gene silencing and benefit from temozolomide in glioblastoma / M.E. Hegi, A.C. Diserens, T. Gorlia et al. // N. Engl. J. Med. – 2005. – Vol. 352, N 10. – P. 997–1003.

110. Hage, V, The NIH stroke scale: a window into neurological status / V.Hage // Nurse, Com Nursing Spectrum (Greater Chicago). – 2011. – Vol. 24, N 15. – P. 44–49.

111. Helseth, R. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme / R. Helseth, E. Helseth,

T.B. Johannesen et al. // Acta. Neurol. Scand. – 2010. –Vol. 122, N 3. – Р. 159–167.

112. Hentschel, S.J. Current surgical management of glioblastoma / S.J. Hentschel,

F.F. Lang // Cancer J. – 2003. –Vol. 9, N 2. – Р. 113.

113. Hirai, T. Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study / T. Hirai, R. Hirai, H. Murakami et al. // Am. J. Neuroradiol. – 2008. –Vol. 29, N 8. – Р. 1505–1510.

114. Hulshof, M.C. Prognostic factors in glioblastoma multiforme.10 years experience of a single institution / M.C. Hulshof, R.W. Koot, E.C. Schimmel, et al. // Strahlenther Onkol. – 2001. –Vol. 177, N 6. – Р. 283–290.

115. Hulsebos, T.J.M. Molecular-genetic characterisation of gliomas that recur as same grade or higher grade tumours / T.J.M. Hulsebos, D. Troost, S. Leenstra // J. Neurol. Neurosurg. Psychiatry. – 2004. –Vol. 75, N 5. – Р. 723–726.

116. Hutton, J.L. Development of prognostic index for primary supratentorial intracerebral tumours / J.L. Hutton, D.F. Smith, D. Sandemann et al. // J. Neurol. Neurosurg. Psychiatry. – 1992. –Vol. 55, N 4. – Р. 271–274.

117. Ino, Y. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss / Y.Ino, M.C. Zlatescu, H.Sasaki et al.// J. Neurosurg. – 2000. – Vol. 92, N 6. – P. 983–990.

118. Ishii, D. Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas / D. Ishii, A. Natsume,

T. Wakabayashi et al. // J.Neurol. Med. Chir. (Tokyo). – 2007. – Vol. 47, N 9. – P.341–349.

119. Jiang, H. A new prognostic scoring scale for patients with primary WHO grade III gliomas based on molecular predictors / H. Jiang, X. Ren, W. Zhang et al. // J. Neurooncol. – 2013. – Vol. 111, N 3. – P. 367–375.

120. Johnston, T. Intraoperative MRI: safety / T. Johnston, R. Moser, K. Moeller et al.

// Neurosurg. Clin. N. Am. – 2009. – Vol. 20. – P. 147–153.

121. Johansson, A. 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors / A. Johansson , G. Palte, O. Schnell et al. // Photochem Photobiol. – 2010. – Vol. 86. – P. 1373–1378.

122. Kamiryo, T. Correlation between promoter hypermethylation of the O6- methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5- pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea-based chemotherapy / T.Kamiryo, K.Tada, S.Shiraishi et al. // Neurosurg. – 2004. – Vol. 54, N 2. – P. 349–357.

123. Karnofsky, D.A. The Clinical Evaluation of Chemotherapeutic Agents in Cancer. In: MacLeod CM (Ed), Evaluation of Chemotherapeutic Agents / D.A. Karnofsky, J.H. Burchenal // Columbia Univ. Press. – 1949. – P.196.

124. Kelty, C.J. The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis / C.J. Kelty, N.J. Brown, M.W. Reed et al. // Photochem. Photobiol. Sci. – 2002. – Vol. 1, N 3. – P. 158–168.

125. Keles, G.E. Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy /

G.E. Keles, K.R. Lamborn, S.M. Chang et al. // J. Neurosurg. – 2004. – Vol. 100. – P. 41–46.

126. Keles, G.E. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma / G.E. Keles, E.F. Chang, K.R. Lamborn et al. // J. Neurosurg. – 2006. – Vol. 105, N 1. – P. 34–40.

127. Kennedy, J.C. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy / J.C. Kennedy, R.H. Pottier // J. Photochem. Photobiol. – 1992. – Vol. 14, N 4. – P. 275-292.

128. Kennedy, J.C. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results / J.C. Kennedy, S.L. Marcus, R.H. Pottier // Journal of Clinical Laser Medicine & Surgery. – 1996. – Vol. 14, N 5. – P. 289 – 304.

129. Kircher, M.F. A Multimodal Nanoparticle for Preoperative Magnetic Resonance Imaging and Intraoperative Optical Brain Tumor Delineation / M.F. Kircher, U. Mahmood, R.S. King et al. // Cancer Res. – 2003. – Vol. 63, N 23. – P. 8122–8125.

130. Klein, A. Photodynamic therapy in dermatology--an update 2008 / A. Klein, P. Babilas, S. Karrer et al. // J. Dtsch. Dermatol. Ges. – 2008. – Vol. 6, N 10. – P. 839–845.

131. Klein, M. Health-related quality of life aspects in patients with low-grade glioma

/ M. Klein // Adv. Tech. Stand. Neurosurg. – 2010. – Vol. 35. – P. 213-235.

132. Koc, K. Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation / K. Koc, I. Anik, B. Cabuk et al. // Br. J. Neurosurg. – 2008. – Vol. 22, N 1. – P. 99–103.

133. Kombos, T. Impact of intraoperative neurophysiological monitoring on surgery of high-grade gliomas / T. Kombos, T. Picht, A. Derdilopoulos et al. // Clin. Neurophysiol. – 2009. – Vol. 26, N 6. – P. 422–425.

134. Konglund A. Surgery for high-grade gliomas in the aging / A. Konglund, R. Helseth, M. Lund-Johansen et al. // Acta Neurol. Scan. – 2013. – Vol.128, N 3. – P. 185–193.

135. Kuhnt, D. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance /

D. Kuhnt, A. Becker, O. Ganslandt et al. // Neuro Oncol. – 2011. – Vol. 13, № 12. – P. 1339–1348.

136. Kurimoto, M. Prognostic Factors in Elderly Patients With Supratentorial Malignant Gliomas / M. Kurimoto, S. Nagai, H. Kamiyama et al. // Neurol. Med. Chir. – 2007. – Vol. 47, N 12. – P. 543–549.

137. Lacroix, M. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival / M. Lacroix, D. Abi-Said, D.R. Fourney et al. // J. Neurosurg . –2001. – Vol. 95, N 20. – P. 190–198.

138. Lamborn, K.R. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis / K.R. Lamborn, S.M. Chang, M.D Prados // Neurooncol. – 2004. – Vol. 6, N 3. – P. 227–235.

139. Lai, A. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme / A. Lai, A. Tran, P.L. Nghiemphu et al. // J. Clin. Oncol. –2011. – Vol. 29, N 2. – P. 142–148.

140. Lang, F.F. Diffusely infiltrative low-grade gliomas in adults / F.F. Lang, M.R. Gilbert // J. Clin. Oncol. – 2006. – Vol.24, N 8. – P. 1236–1245.

141. Laws E.R. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project / E.R. Laws, I.F. Parney, W. Huang et al. // J. Neurosurg. – 2003. – Vol. 99, N. 3. – P. 467–473.

142. Levin, V.A. Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic glioma: NCOG 6G61 final report / V.A. Levin, P. Silver, J. Hannigan et al. // Int. J. Radiat. Oncol. Biol. Phys. – 1990. – Vol.18, N 2. – Р.321–324.

143. Levin, V.A. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treat- ment of anaplastic gliomas / V.A. Levin, W.K. Yung, J. Bruner et al. // Int. J. Radiat. Oncol. Biol. Phys. – 2002. –Vol. 53, N 1

– P. 58–66.

144. Levy, R. Application of intraoperative high-field magnetic resonance imaging in pediatric neurosurgery / R. Levy, R.G. Cox, W.J. Hader et al. // J. Neurosurg. Pediatr. – 2009. –Vol.4, N 5 – P.467 – 474.

145. Lin, W.C. In vivo brain tumor demarcation using optical spectroscopy / W.C. Lin, S.A. Toms, M. Johnson et al. // Photochemistry & Photobiology. – 2001. –Vol. 73 – P. 396–402.

146. Lorenzoni, J. Surgery for high-grade gliomas in a developing country: survival estimation using a simple stratification system / J. Lorenzoni, A. Torrico, P. Willanueva et al.

// Surg. Neurol. – 2008. – Vol. 70, N 6 – P. 591–597.

147. Louis, D.N. WHO Classification of Tumours of the Central Nervous System / Ed, by D.N. Louis, H. Ohgaki, O.D. Wiestler et al. // Lyon IARS. — 2007

148. Macdonald, D.R. Response criteria for phase II studies of supratentorial malignant glioma / D.R.Macdonald, T.L. Cascino, S.C. Schold et al. // J. Clin. Oncol. – 1990.

– Vol. 8, N 7. – P.1277–1280.

149. Maesawa, S. Clinical indications for high-field 1.5 T intraoperative magnetic resonance imaging and neuro-navigation for neurosurgical procedures. Review of initial 100 cases / S. Maesawa, M. Fujii, N. Nakahara et al. // Neurol. Med. Chir. (Tokyo). – 2009. – Vol. 49, N 8. – P.340–350.

150. Mauer, M. The prognostic value of healthrelated quality-of-life data in predicting survival in glioblastoma cancer patients: Results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study / M. Mauer, R. Stupp, M.J. Taphoorn et al. // Br. J. Cancer. – 2007. – Vol. 97, N 3. – P. 302–307.

151. McCormack B.M. Treatment and survival of low-grade astrocytoma in adults-- 1977-1988 / B.M. McCormack, D.C. Miller, G.N. Budzilovich et al. // Neurosurg. – 1992. – Vol. 31, N 4. – P. 636–642.

152. McGirt, M,J, Independent association of extent of resection with survival in patients with malignant brain astrocytoma / M.J. McGirt, K.L. Chaichana, M.Gathinji et al. // J. Neurosurg. – 2010. – Vol. 110, N 1. – P. 156–162.

153. McGirt, M.J. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme / M.J. McGirt, D. Mukherjee,

K.L. Chaichana et al. // Neurosurg. – 2009 – Vol. 65, N 3. – P. 463–469.

154. McKinney, P.A. Brain tumours incidence, survival, and etiology / P.A. McKinney // J. Neurol. Neurosurg. Psychiat. – 2004. – Vol. 75, N 2. – P. 12–17.

155. Meyer, F.B. Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain / F.B. Meyer, L.M. Bates, S.J. Goerss et al. // Mayo. Clin. Proc. – 2001. – Vol. 76, N 7. – P. 677–687.

156. Meyers, C.A. Cognitive function as a predictor of survival in patients with recurrent malignant glioma / C.A. Meyers, K.R. Hess, W.K. Yung et al. // J. Clin. Oncol. – 2000. – Vol. 18, N 3. – P. 646–650.

157. Miyatake, S. Fluorescence of non-neoplastic, magnetic resonance imaging- enhancing tissue by 5-aminolevulinic acid: case report / S. Miyatake, T. Kuroiwa, Y. Kajimoto et al. // Neurosurg. – 2007. –Vol. 61, N 5. – P. 1101–1103.

158. Mohan, D.S. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution /

D.S. Mohan, J.H. Suh, J.L. Phan et al. // Int. J. Radiat. Oncol. Biol. Phys. – 1998. –Vol. 42, N 5. – P. 981–987.

159. Moore, G.E. The clinical use of fluorescein in neurosurgery: the localization of brain tumors / G.E. Moore, W.T. Peyton, L.A. French et al. // J. Neurosurg. – 1948. – Vol. 5.

– P. 392 – 398.

160. Moskowitz, S.I. Role of MIB1 in Predicting Survival in Patients with Glioblastomas / S.I. Moskowitz, T. Jin, R.A. Prayson // J. Neurooncol. – 2006. – Vol. 76, N 2. – P. 193–200.

161. Muller, P.J. Photodynamic therapy of brain tumors – a work in progress / P.J. Muller, B.C. Wilson // Lasers Surg. Med. – 2006. – Vol. 38, № 5. – P. 384–389.

162. Murray, K.J. Improved surgical resection of human brain tumors: Part I. A preliminary study / K.J. Murray // Surg. Neurol. – 1982. – Vol. 17, N 5. – P. 316–319.

163. Nabavi, A. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study / A. Nabavi , H.Thurm, B. Zountsas et al. // Neurosurg. – 2009. – Vol. 65, N 6. – P. 1070–1076.

164. Nikas, D.C. Coregistered intraoperative ultrasonography in resection of malignant glioma / D.C. Nikas, A. Hartov, K. Lunn et al. // Neurosurg. Focus. – 2003. – Vol. 14, N 2. – P. 1–5.

165. Nomiya,T. Prognostic significance of surgery and radiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170cases / T. Nomiya, K. Nemoto, T. Kumabe et al. // J. Neurosurg. – 2007. – Vol. 106, N 4. – P. 575–581.

166. Oken, M.M. Toxicity and response criteria of the Eastern Cooperative Oncology Group / M.M. Oken, R.H. Creech, D.C. Tormey et al. // Am. J. Clin. Oncol. – 1982. – Vol. 5, N 6. – P. 649–655.

167. Olivo, M. Mapping ALA-induced PPIX fluorescence in normal brain and brain tumour using confocal fluorescence microscopy / M. Olivo, B.C. Wilson et al. // Int. J. Oncol. – 2004. – Vol. 25, N 1. – P. 37–45.

168. Orringer, D.A. In Vitro Characterization of a Targeted, Dye-Loaded Nanodevice for Intraoperative Tumor Delineation / D.A. Orringer, Y.E. Koo, T. Chen et al. // Neurosurg.

– 2009. –Vol. 64, N 5. – P. 965–971.

169. Orringer, D.A. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival: Clinical article / D. A. Orringer, D. Lau, S. Khatri et al. // J. Neurosurg. – 2012. –Vol. 117, N 5. – P. 851–859.

170. Osoba, D. Effect of disease burden on health-related quality of life in patients with malignant gliomas / D. Osoba, M. Brada, M.D. Prados et al // Neurooncol. – 2000. – Vol. 2, N 4. – P. 221–228.

171. Osoba, D. Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme / D. Osoba, M. Brada, W.K. Yung et al. // J. Clin. Oncol. – 2000. – Vol. 18, N 7. – P. 1481–1491.

172. Oszvald, A. Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age: Clinical article / A. Oszvald, E. Güresir, M. Setzer et al. // J. Neurosurg. – 2012. – Vol. 116, N 2. – P. 357–364.

173. Otani, N. Awake surgery for glioma resection in eloquent areas: Zurich’s experience and review / N. Otani, M. Bjeljac, C. Muroi et al. // Neurol. Med. Chir. (Tokyo).

– 2005. – Vol. 45, N 10. – P. 501–511.

174. Park, J.K. Scale to predict survival after surgery for recurrent glioblastoma multiforme / J.K. Park, T. Hodges, L. Arko et al. // J. Clin. Oncol. – 2010. – Vol. 28, N 24.

– Р. 3838 – 3843.

175. Pelletier, G. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues / G. Pelletier, M.J. Verhoef, N. Khatri et al. // J. Neurooncol. – 2002. – Vol. 57, N 1. – P. 41–49.

176. Pereira, P.L. Outcome of fully awake craniotomy for lesions near the eloquent cortex: analysis of a prospective surgical series of 79 supratentorial primary brain tumors with long follow-up / P.L. Pereira, K.M. Oliveira, G.L.L. Abbate et al. // Acta Neurochirur. – 2009. – Vol. 151, N 10. – P. 1215-1230.

177. Perry, A. Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors: an analysis of DNA content (ploidy), cellular proliferation, and p53 expression / A. Perry, R.B. Jenkins, J.R. O'Fallon et al. // Cancer. – 1999. – Vol. 86, N 4. – P. 672 – 683.

178. Pichlmeier, U. Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients / U. Pichlmeier, A. Bink, G. Schackert et al. // Neuro Oncol. – 2008. – Vol. 10, N 6. – P. 1025–1034.

179. Pinsker, M.O. Neuronavigation and resection of lesions located in eloquent brain areas under local anesthesia and neuropsychological-neurophysiological monitoring / M.O. Pinsker, A. Nabavi, H.M. Mehdorn // Minim Invasive Neurosurg. –2007. – Vol. 50, N 5. – P. 281–284.

180. Pogue, B.W. Review of Neurosurgical Fluorescence Imaging Methodologies

/ B.W. Pogue , S. GibbsStrauss , P.A. Valdes et al. // IEEE. J. Sel. Top. Quantum. Electron.

– 2010. – Vol. 16, N 3. – P. 493–505.

181. Polin, R.S. Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres / R.S. Polin, N.F. Marko, M.E. Shaffrey et al. // J.Neurosurg. – 2005. – Vol. 102, N 2. – P. 276–283.

182. Pollicard, A. Experimental tumors studied by Wood's light / A. Pollicard // Compt. Rend. Soc. Biol. – 1924 – Vol. 21. – P. 1423–1424.

183. Pope, W.B. MR-imaging correlates of survival in patients with high-grade gliomas / W.B.Pope, J. Sayre, A. Perlina et al. // AJNR. Am. j. neuroradiol. – 2005. – Vol. 26, N 10. – P. 2466–2474.

184. Prados, M.D. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy / M.D. Prados, C. Scott, W.J. Curran et al. // J. Clin. Oncol. – 1999. – Vol. 17, N 11. – P. 3389–3395.

185. Prados, M.D. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma /

M.D. Prados, S.M. Chang, N. Butowski et al. // J. Clin. Oncol. – 2009. – Vol. 27, N 4. – P. 579–584.

186. Preston-Martin, S. Epidemiology of primary CNS neoplasms / S. Preston-Martin

// Neuroepidemiology. – 1996. – Vol. 14, N 2. – P. 273–290.

187. Puduvalli,V.K. Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival / V.K. Puduvalli, M. Hashmi, L.D. McAllister et al. // Oncology. – 2003. – Vol. 65, N 3. – P. 259–266.

188. Pushpan, S.K. Porphyrins in photodynamic therapy - a search for ideal photosensitizers / S.K. Pushpan , S. Venkatraman , V.G. Anand et al. // Anand. Curr. Med. Chem. Anticancer Agents. – 2002. – Vol. 2, N 2. – P. 87–207.

189. Quigley, M.R. The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas / M.R. Quigley, J.C. Maroon // Neurosurg.

– 1991. – Vol. 29, N 3. – P. 385–388.

190. Rahmathulla, G. Surgical briefings, checklists, and the creation of an environment of safety in the neurosurgical intraoperative magnetic resonance imaging suite / G. Rahmathulla, P.F. Recinos, D.E. Traul et al. // Neurosurg. Focus. – 2012. – Vol. 33, N 5. – P. 112.

191. Rampling, R. The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy / R. Rampling, A. James, V. Papanastassiou // J. Neurol .Neurosurg. Psychiatry. – 2004. – Vol.75, N 2. – P. 24–30.

192. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis

/ J. Rankin // Scott. Med. J. – 1957. – Vol. 2, N 5. – P. 200–15.

193. Roberts, D. W. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid–induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters /

D.W. Roberts, P.A. Valdes, B.T. Harris et al. // J. Neurosurg. – 2011. – Vol. 114 – P. 95– 603.

194. Roessler K. Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome / K. Roessler, M. Donat, R. Lanzenberger et al. // J. Neurol. Neurosurg. Psychiatry.

– 2005. – Vol. 76, N 8. – P. 1152–1157.

195. Ronchese, F. The reddish-orange fluorescence of necrotic cancerous surfaces under the Wood light / F. Ronchese, B.S. Walker, R.M. Joung // AMA. Arch. Derm. Syph. – 1954. – Vol. 69, N 1. – P. 31.

196. Sanai, N. Glioma Extent of Resection and Its Impact on Patient Outcome / N. Sanai, M.S. Berger // Neurosurg. – 1954. – Vol. 64, N 4. – P. 753–766.

197. Sanai N. Operative techniques for gliomas and the value of extent of resection /

N. Sanai, M.S. Berger // Neurotherapeutics. – 2009. – Vol. 6, N 3. – Р. 478–486.

198. Sanai, N. An extent of resection threshold for newly diagnosed glioblastomas, Clinical article / N. Sanai, M. Polley, M.W. McDermott et al. // J. Neurosurg. – 2011. – Vol. 115, N 1. – P. 3–8.

199. Sarin, H. Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells / H. Sarin, A.S. Kanevsky, H. Wu et al. // J. Transl. Med. – 2008. – Vol. 6, N 80. – P. 12–17.

200. Scherer, H. Ann. de Chem. u Pharm. / H. Scherer. – 1841 – P. 1–7.

201. Singh, S. Nanotechnology and health safety - Toxicity and risk assessments of nanostructured materials on human health / S. Singh, H.S. Nalwa // J. Nanosci. Nanotechnol.

– 2007. – Vol. 7, N 9. – P. 3048–3070.

202. Shinoda, J. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium: Technical note / J. Shinoda, H. Yano, S. Yoshimura et al. // J. Neurosurg. –2003. – Vol. 99, N 3. – P. 597–603.

203. Schlingensiepen, K.H. Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009. K.H. Schlingensiepen, R. Schlingensiepen , A. Steinbrecher et al. // Growth Factor Rev. – 2006. – Vol. 17, N 1–2. – P. 129–139.

204. Schonherr, B. Quality securing procedures in neurosurgical operations. Experiences with intraoperative computed tomography and neuronavigation / B. Schonherr, А. Grawe, U. Meier // Z. Arztl. Fortbild. Qualitatssich. –1999. –Vol. 93, № 4. – P. 273–280.

205. Scott, J.N. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study / J.N. Scott, N.B. Rewcastle, P.M. Brasher et al. // Ann Neurol. –1999. – Vol. 46, N 2. – P. 183–188.

206. Seliger, C. Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor(TGF)-beta2 and Migration of Glioma Cells In Vitro /

C. Seliger, P. Leukel, S. Moeckel et al. // PLoS. One. –2013. – Vol. 8, № 11. – P. 78–80.

207. Simpson, J.R. Influence of location and extent of surgical resection on sur- vival of patients with glioblastoma multiforme: results of three con- secutive Radiation Therapy Oncology Group(RTOG)clinical trials / J.R. Simpson, J. Horton, C. Scott et al. // Int. J. Radiat. Oncol. Biol. Phys. –1993. – Vol. 26. – P. 239–244.

208. Shaw E.G., Berkey B., Coons S.W. et al. Recurrence following neurosurgeondetermined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial // J. Neurosurg. – 2008. – Vol. 109, № 5. – P. 835–841.

209. Smith, J.S. Role of extent of resection in the longterm outcome of low-grade hemispheric gliomas / J.S. Smith, E.F. Chang, K.R. Lamborn et al. // J. Clin. Oncol. – 2008.

– Vol. 26, N 8. – P. 1338–1345.

210. Solheim, O. Ultrasound-guided operations in unselected high-grade gliomas-- overall results, impact of image quality and patient selection / O. Solheim, T. Selbekk, A.S. Jakola et al. // Acta. Neurochir. (Wien). – 2010. – Vol. 152, N 11. – P. 1873–1886.

211. Stark, A.M. Glioblastoma multiforme report of 267 cases treated at a single institution / A.M. Stark, A. Nabavi, H. Mehdorn et al. // Surg. Neurol. – 2005. – Vol. 63, N 2. – P. 162–169.

212. Stummer,W. Technical Principles for Protoporphyrin-IX-Fluorescence Guided Microsurgical Resection of Malignant Glioma Tissue / W. Stummer, H. Stepp, G. Moller et al. // Acta neurochir. – 1998. – Vol. 140, N 10. – P. 995–1000.

213. Stummer,W. Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients / W. Stummer, A. Novotny, H. Stepp et al. // J. Neurosurg. – 2000. – Vol. 93, N 6. – P. 1003–1013.

214. Stummer,W. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial / W. Stummer, U. Pichlmeier, T. Weistler et al. // Lancet Oncol. – 2006. – Vol. 7. –P. 392–401.

215. Stummer,W. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias / W. Stummer, H.J. Reulen, T. Meinel et al. // Neurosurg. – 2008. – Vol. 62, N 3. – P. 564–576.

216. Stummer, W. The importance of surgical resection in malignant glioma / W. Stummer, M.A. Kamp // Curr. Opin. Neurol. – 2009. – Vol. 22, N 6. – P. 645–649.

217. Stummer, W. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study Clinical article / W. Stummer , J.C.Tonn , H.M. Mehdorn et al. // J. Neurosurg. – 2011. – Vol. 114, N 3. – P. 613–623.

218. Stupp, R. Current and future developments in the use of temozolomide for the treatment of brain tumours / R. Stupp, M. Gander, S. Leyvraz et al. // Lancet Oncol. – 2001.

– Vol. 2, N 9. – P. 552–560.

219. Stupp, R. Optimal role of temozolomide in the treatment of malignant gliomas /

R. Stupp, M.J. Van den Bent, M.E. Hegi // Curr. Neurol. Neurosci. Rep. – 2005. – Vol.5, N 3. – P.198–206.

220. Stupp, R. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma / R. Stupp, W.P. Mason, M.J. van den Bent et al. // N. Engl. J. Med. – 2005. – Vol. 352, N 10. – P. 987–996.

221. Stupp, R. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma / R. Stupp, M.E. Hegi, B. Neyns et al. // J. Clin. Oncol. – 2010. – Vol. 28, N 16. – P. 2712–2718.

222. Suess, O. A new cortical electrode for neuronavigation-guided intraoperative neurophysiological monitoring: technical note / O. Suess, T. Kombos, T. Hoell // Acta Neurochir. (Wien). – 2000. – Vol. 142, N 3. – P. 329–361.

223. Deoarah S. Trends in brain Cancer Incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001/ S. Deoarah, C.F. Lynch, Z.A. Sibenaller et al. // Neurosurg. Focus. – 2006. – Vol. 20, N 4. – P. 29–35.

224. Taphoorn, M.J. Health-related quality of life in patients with glioblastoma: A randomised controlled trial / M.J. Taphoorn, R. Stupp, C.Coens et al. // Lancet Oncol. – 2005. – Vol.6, N 12. – P. 937–944.

225. Taphoorn, M.J. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients / M.J. Taphoorn, L. Claassens, N.K. Aaronson et al. // Eur. J. Cancer. – 2010. – Vol. 46. – P.1033–1040.

226. Toda, M. Intraoperative navigation and fluorescence imagings in malignant glioma surgery / M.Toda // Kei. J. Med. – 2008. – Vol. 57. – P. 155–161.

227. Toms, S.A. Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity / S.A. Toms, W.C. Lin, R.J. Weil et al. // Neurosurg. – 2005. – Vol. 57, N 4. – P. 382–391.

228. Tortosa, A. Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas / A.Tortosa, N. Viñolas, S. Villà et al. // Cancer. – 2003. – Vol. 97, N 4. – P. 1063–1071.

229. Trehin, R. Fluorescent nanoparticle uptake for brain tumor visualization / R. Trehin, J.L. Figueiredo, M.J. Pittet et al. // Neoplasia. – 2006. – Vol. 8, № 4. – P. 302–311.

230. Tronnier, V.M. Comparison of intraoperative MR imaging and 3D-navigated ultrasonography in the detection and resection control of lesions / V.M. Tronnier, M.M. Bonsanto, A. Staubert et al. // Neurosurg. Focus. – 2001. – Vol. 10, N 2. –Article 3.

231. Tsugu, A. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma / A. Tsugu , H. Ishizaka , Y. Mizokami et al. // World Neurosurg. – 2011. – Vol. 76, N 1/2. – P. 120–127.

232. Unsgaard, G. Neuronavigation by intraoperative three-dimensional ultrasound: initial experience during brain tumor resection / G. Unsgaard, S. Ommedal, T. Muller et al. // Neurosurg. – 2002. – Vol. 50, N 4. – P. 804–812.

233. Unsgaard, G. Intra-operative 3D ultrasound in neurosurgery / G. Unsgaard, O.M. Rygh, T. Selbekk et al. // Acta Neurochirurgica. – 2006. – Vol. 148, N 3. – P. 235–253.

234. Ushio,Y. Effect of surgical lremoval on survival and quality of life in patients with supratentorial glioblastoma / Y.Ushio, M. Kochi, J. Hamada et al. // Neurol. Med. Chir.(Tokyo). – 2005. – Vol. 45, N 9. – P. 454–460.

235. Utsuki, S. Histological examination of false positive tissue resection using 5- aminolevulinic acid-induced fluorescence guidance / S. Utsuki, H.Oka, S. Sato et al. // Neurol. Med. Chirur. – 2007. – Vol. 47, N 5. – P. 210–213.

236. Uzuka, T. Surgical strategy for malignant glioma resection with intraoperative use of fluorescein Na / T. Uzuka, H. Takahashi, Y. Fuji // Neurolog. Surg. – 2007. – Vol. 35, N 6. – P. 557–562.

237. Valdes, P.A. Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resection / P.A. Valdes, X. Fan, S. Ji et al. // Stereotact. Funct. Neurosurg. – 2010. – Vol. 88, N 1. – P. 1–10.

238. Valdes, P.A. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. Clinical article / P.A. Valdes, F. Leblond, A. Kim et al. // J. Neurosurg. – 2011. – Vol. 115, N 1. – P. 11–7.

239. van den Bent, M.J. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial / M.J. van den Bent , A.F. Carpentier, A.A. Brandes et al. // J. Clin Oncol. – 2006. – Vol. 24, N 18. – P. 2715–2722.

240. van den Bent, M.J. MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951 / M.J. van den Bent, H.J. Dubbink, M. Sanson et al. // J. Clin. Oncol. – 2009. – Vol. 27, N 35. – P. 5881–5886.

241. van Swieten, J. Interobserver agreement for the assessment of handicap in stroke patients / J. van Swieten, P. Koudstaal, M.Visser et al. // Stroke. – 1988. – Vol. 19, N 5. – P. 604–607.

242. Vauleon, E. Overview of cellular immunotherapy for patients with glioblastoma /

E. Vauleon, T. Avril, B. Collet et al. // Clin. Dev. Immunol. – 2010. – Vol. 35, N 6. – P. 1– 18.

243. Vecht, C.J. The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients / C.J. Vecht, C.J. Avezaat, W.L. van Putten et al. // Neurol. Neurosurg. Psychiatry. – 1990. – Vol. 53, N 6. – P. 466–467.

244. Wager, M. Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study / M. Wager, P. Menei, J. Guilhot et al. // British Journal of Cancer. – 2008. – Vol. 98, N 11. – P.1830 – 1838.

245. Walker, M.D. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial / M.D. Walker, E. Alexander, W.E. Hunt et al. // J. Neurosurg. – 1978. – Vol. 49, N 3. – P. 333–343.

246. Weitzner, M.A. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in

patients with primary brain tumors / M.A. Weitzner, C.A. Meyers, C.K. Gelke et al. //

Cancer. – 1995. – Vol. 75, N 5. – P. 1151–1161.

247. Weitzner, M.A. Psychosocial and neuropsychiatric aspects of patients with primary brain tumors / M.A.Weitzner // Cancer Invest. – 1999. – Vol. 17, № 4. – P. 285–291.

248. Weller, M. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network / M. Weller, J. Felsberg, C. Hartmann et al. // J. Clin. Oncol. – 2009. – Vol. 27, N 24. – P. 5743–5750.

249. Wen, P.Y. Malignant gliomas in adults / P.Y. Wen, S.N. Kesari // Engl. J. Med. – 2008. – Vol. 359, N 5. – P. 492–507.

250. Wilkinson, I.D. Motor functional MRI for preoperative and intraoperative neurosurgical guidance / I.D. Wilkinson, C.A. Romanowski, D.A. Jellinek et al. // Brit. J. Radiol. – 2003. – N 76. – P. 98–103.

251. Wisoff, J.H. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group Trial No. CCG-945 / J.H. Wisoff, J.M. Boyett, M.S. Berger et al. // J. Neurosurg. – 1998. – Vol. 89, N 1. – P. 52–59.

252. Wrensch, M. Epidemiology of primary brain tumors: current concepts and review of the literature / M. Wrensch, Y. Minn, T. Chew // Neurooncology. – 2002. – Vol.4, N 9. – P.278–299.

253. Woodburn, K. Effect of density-gradients on the binding of photosensitizing agents to plasma proteins / K. Woodburn , D. Kessel // Int. J. Biochem. Cell. Biol. – 1995. – Vol. 27, N 5. – P. 499–506.

254. Wu, J. Clinical evaluation and follow-up outcome of diffusion tensor imaging- based functional neuronavigation / J.Wu , L. Zhou, W. Tang et al. // Neurosurg. – 2007. – Vol. 61, N 5. – P. 935–949.